GT Biopharma, Inc.GTBPNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR-40.1%
5Y CAGR-19.9%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-40.1%/yr
Annual compound
5Y CAGR
-19.9%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 13.52% |
| 2024 | -5.80% |
| 2023 | 36.13% |
| 2022 | 63.04% |
| 2021 | -750.31% |
| 2020 | 40.96% |
| 2019 | 95.42% |
| 2018 | -84.46% |
| 2017 | -1346.23% |
| 2016 | -5.01% |